Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
Saved in:
| Main Authors: | Warren Fiskus, Christopher P. Mill, Christine Birdwell, John A. Davis, Kaberi Das, Steffen Boettcher, Tapan M. Kadia, Courtney D. DiNardo, Koichi Takahashi, Sanam Loghavi, Michael J. Soth, Tim Heffernan, Gerard M. McGeehan, Xinjia Ruan, Xiaoping Su, Christopher R. Vakoc, Naval Daver, Kapil N. Bhalla |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01306-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
by: Warren Fiskus, et al.
Published: (2023-04-01) -
Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy
by: Wei-Ying Jen, et al.
Published: (2025-02-01) -
Unveiling the Mysteries of Molecular Testing in AML: A Guide for Oncologists [Podcast]
by: Zeidan AM, et al.
Published: (2025-06-01) -
Functional cure with single agent olutasidenib in relapsed IDH1/NPM1 co-mutated AML
by: Justin Watts, et al.
Published: (2025-07-01) -
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
by: Sibylle Cocciardi, et al.
Published: (2025-01-01)